Median Technologies is engaged in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development. The firm intends to target the oncology clinical trials market and the cancer patient care market. It developed software-based tools that are integrated into a clinical application portfolio called Lesion Management Solutions. The company has two platforms, iSee for imaging services in clinical trials and eyonis for non-invasive diagnostic tests based on imaging for the treatment of patients suffering from cancer and other chronic diseases. Geographically, the company generates revenue from EMEA, the USA/Canada, and China.
2002
164
LTM Revenue $28.6M
LTM EBITDA -$22.4M
$63.2M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Median Technologies has a last 12-month revenue (LTM) of $28.6M and a last 12-month EBITDA of -$22.4M.
In the most recent fiscal year, Median Technologies achieved revenue of $27.0M and an EBITDA of -$22.7M.
Median Technologies expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Median Technologies valuation multiples based on analyst estimatesLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue | $28.6M | XXX | $27.0M | XXX | XXX | XXX |
Gross Profit | n/a | XXX | $28.1M | XXX | XXX | XXX |
Gross Margin | n/a | XXX | 104% | XXX | XXX | XXX |
EBITDA | -$22.4M | XXX | -$22.7M | XXX | XXX | XXX |
EBITDA Margin | -78% | XXX | -84% | XXX | XXX | XXX |
EBIT | -$24.4M | XXX | -$26.4M | XXX | XXX | XXX |
EBIT Margin | -85% | XXX | -97% | XXX | XXX | XXX |
Net Profit | -$27.4M | XXX | -$29.7M | XXX | XXX | XXX |
Net Margin | -96% | XXX | -110% | XXX | XXX | XXX |
Net Debt | XXX | XXX | $23.8M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 2, 2025, Median Technologies's stock price is EUR 2 (or $2).
Median Technologies has current market cap of EUR 32.4M (or $38.2M), and EV of EUR 53.6M (or $63.2M).
See Median Technologies trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$63.2M | $38.2M | XXX | XXX | XXX | XXX | $-1.22 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 2, 2025, Median Technologies has market cap of $38.2M and EV of $63.2M.
Median Technologies's trades at 2.3x EV/Revenue multiple, and -2.8x EV/EBITDA.
Equity research analysts estimate Median Technologies's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Median Technologies has a P/E ratio of -1.4x.
See valuation multiples for Median Technologies and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $38.2M | XXX | $38.2M | XXX | XXX | XXX |
EV (current) | $63.2M | XXX | $63.2M | XXX | XXX | XXX |
EV/Revenue | 2.2x | XXX | 2.3x | XXX | XXX | XXX |
EV/EBITDA | -2.8x | XXX | -2.8x | XXX | XXX | XXX |
EV/EBIT | -2.6x | XXX | -2.4x | XXX | XXX | XXX |
EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
P/E | -1.4x | XXX | -1.3x | XXX | XXX | XXX |
EV/FCF | -2.8x | XXX | -2.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialMedian Technologies's last 12 month revenue growth is 15%
Median Technologies's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.3M for the same period.
Median Technologies's rule of 40 is -74% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Median Technologies's rule of X is -40% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Median Technologies and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | 15% | XXX | 15% | XXX | XXX | XXX |
EBITDA Margin | -78% | XXX | -84% | XXX | XXX | XXX |
EBITDA Growth | -20% | XXX | n/a | XXX | XXX | XXX |
Rule of 40 | -74% | XXX | -69% | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | -40% | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | 4% | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 201% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Philips | XXX | XXX | XXX | XXX | XXX | XXX |
Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Median Technologies acquired XXX companies to date.
Last acquisition by Median Technologies was XXXXXXXX, XXXXX XXXXX XXXXXX . Median Technologies acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was Median Technologies founded? | Median Technologies was founded in 2002. |
Where is Median Technologies headquartered? | Median Technologies is headquartered in France. |
How many employees does Median Technologies have? | As of today, Median Technologies has 164 employees. |
Who is the CEO of Median Technologies? | Median Technologies's CEO is Mr. Fredrik Brag. |
Is Median Technologies publicy listed? | Yes, Median Technologies is a public company listed on PAR. |
What is the stock symbol of Median Technologies? | Median Technologies trades under ALMDT ticker. |
When did Median Technologies go public? | Median Technologies went public in 2011. |
Who are competitors of Median Technologies? | Similar companies to Median Technologies include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
What is the current market cap of Median Technologies? | Median Technologies's current market cap is $38.2M |
What is the current revenue of Median Technologies? | Median Technologies's last 12 months revenue is $28.6M. |
What is the current revenue growth of Median Technologies? | Median Technologies revenue growth (NTM/LTM) is 15%. |
What is the current EV/Revenue multiple of Median Technologies? | Current revenue multiple of Median Technologies is 2.2x. |
Is Median Technologies profitable? | Yes, Median Technologies is EBITDA-positive (as of the last 12 months). |
What is the current EBITDA of Median Technologies? | Median Technologies's last 12 months EBITDA is -$22.4M. |
What is Median Technologies's EBITDA margin? | Median Technologies's last 12 months EBITDA margin is -78%. |
What is the current EV/EBITDA multiple of Median Technologies? | Current EBITDA multiple of Median Technologies is -2.8x. |
What is the current FCF of Median Technologies? | Median Technologies's last 12 months FCF is -$22.8M. |
What is Median Technologies's FCF margin? | Median Technologies's last 12 months FCF margin is -80%. |
What is the current EV/FCF multiple of Median Technologies? | Current FCF multiple of Median Technologies is -2.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.